Transcriptomic analysis demonstrated that MMP2, MMP7, MMP16, MMP19, MMP23, and MMP28 were significantly upregulated in both male and female NSCLC patients with elevated tumoral GHR expression. The gene discussed is MMP19; the disease is non-small cell lung carcinoma.